Related Experiment Videos

[The cardiovascular manifestations of Paget's disease]

Revue Du Rhumatisme Et Des Maladies Osteo-Articulaires
|October 1, 1975
PubMed

Insights

This study on Paget's disease found frequent, often latent, cardiac issues like conduction and repolarization disorders. Calcitonin showed promise in treating these cardiovascular manifestations.

Area of Science:

  • Cardiology
  • Endocrinology
  • Rheumatology

Background:

  • Paget's disease of bone is a chronic disorder affecting bone remodeling.
  • Previous hypotheses on cardiovascular involvement include peripheral syndrome and vascular calcification.
  • Cardiac manifestations in Paget's disease are often underdiagnosed due to latency.

Purpose of the Study:

  • To investigate the prevalence and characteristics of cardiac manifestations in patients with Paget's disease.
  • To analyze electrocardiographic findings in relation to patient and disease parameters.
  • To explore potential therapeutic strategies for cardiac involvement.

Main Methods:

  • Retrospective analysis of 150 patients with Paget's disease followed over several years.
  • Systematic cardiac evaluation using electrocardiography (ECG).
  • Correlation of ECG findings with patient demographics (age, sex) and disease characteristics (evolution, diffusion).

Main Results:

  • 91 out of 150 patients exhibited ECG disturbances.
  • Conduction disorders were observed in 43 cases, and repolarization disorders in 48 cases.
  • Cardiac issues were more frequent during evolutive stages of Paget's disease.

Conclusions:

  • Cardiac manifestations are common and often latent in Paget's disease, necessitating systematic ECG monitoring.
  • Understanding the distribution of ECG disorders aids in patient stratification.
  • Calcitonin demonstrated anti-arrhythmic potential and positive therapeutic effects in preliminary observations.

Related Concept Videos